A brain trauma?Alzheimer’s disease connection
Nature Medicine
March 16, 2009
Two enzymes implicated in Alzheimer’s disease may also have a role in traumatic brain injury, according to research online this week in Nature Medicine.
Amyloid-beta peptides, pathological hallmarks of Alzheimer’s disease, accumulate rapidly after traumatic brain injury in humans. Mark Burns and his colleagues now show that blocking either beta- or gamma-secretase, enzymes required for production of Amyloid-beta, can reduce deficits in movement and behavior and reduce neuronal loss after experimentally inflicted brain injury in mice.
The authors propose that these two secretases, which are being actively pursued in the fight against Alzheimer’s disease, could also be promising targets to treat traumatic brain injury.
doi: 10.1038/nm.1940
Research highlights
-
Dec 1
Neurodegenerative disease: Two blood molecules may predict Alzheimer’s disease developmentNature Aging
-
Nov 27
Archaeology: Neanderthal thumbs better adapted to holding tools with handlesScientific Reports
-
Nov 26
Metabolism: Link between SARS-CoV-2 infection and cholesterol hints at COVID-19 treatment possibilitiesNature Metabolism
-
Nov 26
Evolution: Ancient bird sticks its big beak into the evolutionary recordNature
-
Nov 25
Stem cells: Modelling SARS-CoV-2 lung infection in a dishNature
-
Nov 25
Zoology: Mineral armour discovered in insectsNature Communications
